Legend Biotech Corporation American Depositary Shares (LEGN)

Price$32.62

Value ScoreC

Growth ScoreA

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)9.79%

Price vs S&P 500 (4W)16.01%

VGM Score67.11

Market Capitalization$6.35B

All Metrics

Book Value / Share (Quarterly)$2.71

P/TBV (Annual)5.75x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)106.41%

Cash Flow / Share (Quarterly)$-0.35

Price vs S&P 500 (YTD)41.89%

Gross Margin (TTM)54.99%

Net Profit Margin (TTM)-21.97%

EPS (TTM)$-0.68

10-Day Avg Trading Volume3.66M

EPS Excl Extra (TTM)$-0.68

Revenue Growth (5Y)68.83%

EPS (Annual)$-0.81

ROI (Annual)-20.96%

Gross Margin (Annual)60.34%

Net Profit Margin (5Y Avg)-241.38%

Cash / Share (Quarterly)$2.56

Revenue Growth QoQ (YoY)56.42%

ROA (Last FY)-17.12%

Revenue Growth TTM (YoY)56.39%

EBITD / Share (TTM)$-0.26

ROE (5Y Avg)-40.14%

Operating Margin (TTM)-11.83%

Cash Flow / Share (Annual)$-0.35

P/B Ratio6.56x

P/B Ratio (Quarterly)3.46x

Net Income / Employee (Annual)$-102,300

EV / Revenue (TTM)5.35x

Net Interest Coverage (TTM)-0.88x

ROA (TTM)-14.86%

EPS Incl Extra (Annual)$-0.81

Current Ratio (Annual)1.96x

Quick Ratio (Quarterly)2.02x

3-Month Avg Trading Volume2.33M

52-Week Price Return3.62%

Revenue / Employee (TTM)$392,800

Tangible BV / Share (Quarterly)$2.80

P/S Ratio (Annual)6.17x

Asset Turnover (Annual)0.59x

52-Week High$45.30

Operating Margin (5Y Avg)-242.40%

EPS Excl Extra (Annual)$-0.81

CapEx CAGR (5Y)-10.50%

Tangible BV CAGR (5Y)127.48%

26-Week Price Return17.72%

Quick Ratio (Annual)1.89x

13-Week Price Return83.77%

Total Debt / Equity (Annual)0.41x

Current Ratio (Quarterly)2.13x

Enterprise Value$6.10B

Revenue / Share Growth (5Y)54.47%

Asset Turnover (TTM)0.68x

Book Value / Share Growth (5Y)116.84%

Revenue / Employee (Annual)$354,800

Inventory Turnover (Annual)14.60x

Pretax Margin (Annual)-27.47%

Cash / Share (Annual)$2.56

3-Month Return Std Dev110.27%

Net Income / Employee (TTM)$-86,300

ROE (Last FY)-29.62%

Net Interest Coverage (Annual)-0.80x

EPS Basic Excl Extra (Annual)$-0.81

Receivables Turnover (TTM)1100.99x

Total Debt / Equity (Quarterly)0.40x

EPS Incl Extra (TTM)$-0.68

Receivables Turnover (Annual)106.14x

ROI (TTM)-17.81%

P/S Ratio (TTM)5.58x

Pretax Margin (5Y Avg)-241.58%

Revenue / Share (Annual)$2.79

Tangible BV / Share (Annual)$2.83

Forward P/E53.41x

Price vs S&P 500 (52W)-20.74%

Year-to-Date Return50.05%

5-Day Price Return27.87%

EPS Normalized (Annual)$-0.81

ROA (5Y Avg)-25.07%

Net Profit Margin (Annual)-28.85%

Month-to-Date Return20.10%

EBITD / Share (Annual)$-0.29

Operating Margin (Annual)-13.27%

LT Debt / Equity (Annual)0.29x

ROI (5Y Avg)-31.05%

LT Debt / Equity (Quarterly)0.17x

EPS Basic Excl Extra (TTM)$-0.68

P/TBV (Quarterly)6.34x

P/B Ratio (Annual)3.97x

Inventory Turnover (TTM)15.07x

Pretax Margin (TTM)-20.77%

Book Value / Share (Annual)$2.71

Price vs S&P 500 (13W)75.52%

Beta0.29x

P/FCF (Annual)22.16x

Revenue / Share (TTM)$3.08

ROE (TTM)-24.92%

52-Week Low$16.24

vGradeC

gGradeA

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.30est. -0.02

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.12

4.17

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
LEGNLegend Biotech Corporation American Depositary Shares	C	A	B	$32.62
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Legend Biotech is a biopharmaceutical company developing cell therapies for cancer treatment. Its lead program, LCAR-B38M/JNJ-4528, is a CAR-T therapy in development for multiple myeloma. The company generates revenue through licensing and collaboration agreements, primarily with US partners.